Strategic Communications and Marketing News Bureau

Assembly Hall to sell alcohol during pilot program

The Assembly Hall will introduce a pilot alcohol sales program this month at select shows targeted toward adults. Alcohol sales will be limited to beer and wine. The pilot program is in effect at Cirque du Soleil’s “Alegria,” which continues through March 21, and “Cabaret” on April 24.

Additional events targeted toward adults also are being considered. Sales will not take place during events that draw a large number of students.

For a number of years, Assembly Hall management has been at a disadvantage competing for national touring shows because the venue does not sell alcoholic beverages, unlike competing venues in Bloomington, Chicago (including the UIC Pavilion), Peoria and Springfield. “We’ve actually lost shows to the U.S. Cellular Coliseum in Bloomington and Peoria Civic Center because they sell alcohol and we don’t,” said Kevin Ullestad, the director of the Assembly Hall.

Consumer feedback also has driven the pilot program. “It is important that we respond to marketplace needs,” Ullestad said. “For some adult audiences, having an alcoholic beverage while enjoying a show has become an expectation, and, this is something the Krannert Center for the Performing Arts has been doing successfully for years.”

University President Stanley O. Ikenberry and Chancellor Bob Easter have both approved the pilot program. Assembly Hall will be required to provide a written report to university administration at the end of the pilot program to determine whether to continue alcohol sales.

Several Assembly Hall staff members have become TIPS certified (Training for Intervention ProcedureS), which provides instruction in the responsible service, sale and consumption of alcohol. A detailed service plan has been developed by the Assembly Hall to manage and monitor the program. Designated alcohol serving stations will be set up where no other concession products will be sold; all Illinois Liquor Commission policies and regulations will be strictly enforced. IDs will be checked as necessary, wrist bands will be issued and drink limits will be enforced.



This article was imported from a previous version of the News Bureau website. Please email news@illinois.edu to report missing photos and/or photo credits.

Read Next

Uncategorized Professor Sandraluz Lara-Cinisomo and co-authors Melany Romero and Sudhamshi Beeram.

Postpartum depression linked with seven pain-related risk factors

CHAMPAIGN, Ill. — A woman’s risk of developing postpartum depression is influenced by several pain-related factors before and after childbirth, including poor pain management, their prenatal mental health and the quality of patient-provider communication, researchers at the University of Illinois Urbana-Champaign say. Health and kinesiology professor Sandraluz Lara-Cinisomo and her co-authors, graduate students Sudhamshi Beeram […]

Health and Medicine A group of people standing in a lab

Alzheimer’s gene boosts seizures, but pathway can be targeted, study finds

CHAMPAIGN, Ill. — The gene most strongly correlated with Alzheimer’s disease also boosts seizure activity by decreasing levels of ions pumps and energy-producing enzymes in neurons, a new study by researchers at the University of Illinois Urbana-Champaign found. Furthermore, the energy-making pathway was stimulated and seizures reduced in mouse models of Alzheimer’s disease by administration […]

Health and Medicine Photo of Jacob S. Sherkow, a professor of law and of medicine at Illinois.

Paper: FDA-required drug labels shouldn’t be treated as evidence of patent infringement

Drug labels required by the U.S. FDA are intended to guide the safe and effective use of prescription drugs, but the hyperbolic claims of patent infringement by drug companies is tantamount to “patent gamesmanship,” said Jacob S. Sherkow, a professor of law and of medicine at Illinois.

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010